HomeCompareUUICF vs JNJ

UUICF vs JNJ: Dividend Comparison 2026

UUICF yields 4.56% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UUICF wins by $18.5K in total portfolio value
10 years
UUICF
UUICF
● Live price
4.56%
Share price
$1,177.83
Annual div
$53.70
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.5K
Annual income
$3,329.04
Full UUICF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — UUICF vs JNJ

📍 UUICF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUUICFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UUICF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UUICF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UUICF
Annual income on $10K today (after 15% tax)
$387.57/yr
After 10yr DRIP, annual income (after tax)
$2,829.68/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, UUICF beats the other by $2,126.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UUICF + JNJ for your $10,000?

UUICF: 50%JNJ: 50%
100% JNJ50/50100% UUICF
Portfolio after 10yr
$29.3K
Annual income
$2,078.41/yr
Blended yield
7.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

UUICF
No analyst data
Altman Z
1.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UUICF buys
0
JNJ buys
0
No recent congressional trades found for UUICF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUUICFJNJ
Forward yield4.56%3.36%
Annual dividend / share$53.70$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR15.1%5.8%
Portfolio after 10y$38.5K$20.0K
Annual income after 10y$3,329.04$827.78
Total dividends collected$15.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UUICF vs JNJ ($10,000, DRIP)

YearUUICF PortfolioUUICF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,225$524.81$10,676$355.77+$549.00UUICF
2$12,644$633.68$11,407$389.39+$1.2KUUICF
3$14,297$767.85$12,198$426.53+$2.1KUUICF
4$16,232$933.96$13,056$467.62+$3.2KUUICF
5$18,509$1,140.61$13,987$513.12+$4.5KUUICF
6$21,203$1,399.06$14,998$563.56+$6.2KUUICF
7$24,412$1,724.08$16,098$619.52+$8.3KUUICF
8$28,256$2,135.21$17,295$681.69+$11.0KUUICF
9$32,892$2,658.53$18,599$750.82+$14.3KUUICF
10$38,524$3,329.04$20,022$827.78+$18.5KUUICF

UUICF vs JNJ: Complete Analysis 2026

UUICFStock

United Urban was listed in the real estate investment trust section of the Tokyo Stock Exchange (the J-REIT section) in December 2003 as a diversified J-REIT, investing in properties varied both in types of use and geographical location. Since its listing, United Urban has been making efforts to maintain or improve its revenues and reduce various risks for the purpose of obtaining stable earnings over the medium to long term.

Full UUICF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this UUICF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UUICF vs SCHDUUICF vs JEPIUUICF vs OUUICF vs KOUUICF vs MAINUUICF vs ABBVUUICF vs MRKUUICF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.